Richie Manikat, Aijaz Ahmed,* Donghee Kim* Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA*These authors contributed equally to this workCorrespondence: Donghee Kim, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA, 94304, USA, Tel +1-650-497-9261, Fax +1-650-498-5692, transpharm online shopping Email [email protected]; [email protected]: The coronavirus disease 2019 (COVID-19) pandemic has caused significant shifts in alcohol consumption patterns in the United States, with potential long-term implications for liver transplantation (LT) programs.Alcohol consumption has increased, particularly in women, leading to a rise in alcohol-related liver disease (ALD) and alcohol use disorder.
Psychological distress associated with the pandemic may further exacerbate alcohol addiction.ALD is now the most common hp pavilion 15-eg1053cl indication for LT, with higher disease severity and complex clinical presentations, demanding a fundamental transformation in LT programs.Multidisciplinary cooperation among medical specialists, telemedicine, and remote healthcare are essential strategies to address these challenges.However, barriers to telemedicine and costs must be overcome.
Curbing alcohol consumption at the societal level and bolstering mental health programs to mitigate healthcare workforce moral injury are recommended to optimize patient care in the post-COVID-19 era.Adequate planning and compassionate management of finite resources will be crucial for the successful continuation of LT programs amidst the concerning trends in alcohol consumption and addiction.Keywords: alcohol-related liver disease, alcohol use disorder, COVID-19, trend.